Additionally, persistent dyspnea and myalgia and higher serum levels of Krebs von den Lungen 6 (KL-6) at follow-up were associated with a greater risk of occurrence of post-COVID pulmonary fibrosis [31, 37, 38]. This evidence concerns the gene MUC1 and Myalgia.